Tumor Heterogeneity
Tumor Heterogeneity - Related Videos
07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
0 Views •
Cited by 27 •
2011
Here we describe a method to quantify molecular heterogeneity in histological sections of tumor material using quantitative immunofluorescence, image analysis, and a statistical measure of heterogeneity. The method is intended for use in clinical biomarker development and analysis.
01:22
Heterogeneous Catalysis
0 Views •
2026
Heterogeneous catalysis involves a catalyst in a different phase from the reactants. It is a process where the catalyst and the reactants are in distinct phases, typically solid and gas or liquid.Most heterogeneous catalysts are metals, metal oxides, or acids. The list includes transition metals like iron (Fe), cobalt (Co), nickel (Ni), palladium (Pd), platinum (Pt), chromium (Cr), manganese (Mn), tungsten (W), silver (Ag), and copper (Cu). These metals possess partially vacant d orbitals that...
11:15
HKUST-1 as a Heterogeneous Catalyst for the Synthesis of Vanillin
0 Views •
Cited by 12 •
2016
The conversion of trans-ferulic acid to vanillin was achieved by heterogeneous catalysis. HKUST-1 was employed in this synthesis and the essential step in the catalytic process was the generation of unsaturated metal sites. Thus, when the catalyst was activated under vacuum, full vanillin conversion (yield of 95%) was obtained.
04:43
Single-Cell Western Blotting to Determine Cell Heterogeneity
0 Views •
2025
The video describes a single-cell western blotting technique that identifies the composition of individual cells captured on a single-cell western blotting chip in a heterogeneous suspension. The technique detects the fluorescence intensity of the fluorophore tagged to a protein marker specific to the target cell.
07:11
Sampling Soils in a Heterogeneous Research Plot
0 Views •
Cited by 21 •
2019
The traditional soil-sampling procedure determines the number of soil samples arbitrarily. Here, we provide a simple yet efficient clustered soil-sampling design to demonstrate soil spatial heterogeneity and quantitatively determine the number of soil samples required and the associated sampling accuracy.
FAQs
Accumulated mutations and epigenetic changes produce subclones with distinct molecular and cellular properties. These subclones can interact differently with the surrounding tumor microenvironment, leading some populations to support tumor growth or spread more effectively than others. Their coexistence helps explain why a single tumor may contain regions with different functional behavior and clinical significance.
Genetic mutations and epigenetic changes provide distinct sources of variation among cancer-cell populations. As these alterations accumulate, they can influence cellular function, treatment sensitivity, and disease behavior. Evaluating both types of change therefore gives a broader view of tumor complexity than examining one molecular feature alone, which is relevant to prognosis and treatment selection.
Cancer-cell populations within the same tumor may respond differently to therapy because they carry distinct molecular and functional features. Treatment can reduce sensitive populations while resistant populations persist, leaving a source for continued disease. Recognizing this possibility is important when interpreting treatment response and when investigating why therapy may not eliminate all cancer cells.
Biopsy analysis, single-cell sequencing, and spatial profiling are among the approaches used to examine variation within tumors. Biopsy analysis samples tumor material, single-cell sequencing supports assessment of individual cancer-cell populations, and spatial profiling helps relate observed features to their location. Together with related methods, these approaches support more detailed tumor characterization.
Assessment is useful when researchers need to refine diagnosis, estimate prognosis, or select treatments that reflect differences among cancer-cell populations. It can also clarify patterns of tumor progression, metastasis, and therapeutic resistance. In medicine, this information supports more precise interpretation of disease behavior rather than treating every cell in a tumor as biologically identical.
Different subclones and their interactions with the tumor microenvironment can influence how a cancer grows and spreads. Because these populations may also differ in treatment sensitivity, their composition can affect whether resistant cells remain after therapy. Characterizing this variation may therefore improve understanding of metastasis, prognosis, and differences in outcomes between patients.